These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34572579)

  • 1. Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 M
    Thissera B; Sayed AM; Hassan MHA; Abdelwahab SF; Amaeze N; Semler VT; Alenezi FN; Yaseen M; Alhadrami HA; Belbahri L; Rateb ME
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoechinulin A as a Promising SARS-CoV-2 M
    Alhadrami HA; Burgio G; Thissera B; Orfali R; Jiffri SE; Yaseen M; Sayed AM; Rateb ME
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from
    Al-Karmalawy AA; Alnajjar R; Elmaaty AA; Binjubair FA; Al-Rashood ST; Mansour BS; Elkamhawy A; Eldehna WM; Mansour KA
    J Biomol Struct Dyn; 2024 Aug; 42(13):6941-6953. PubMed ID: 37505066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.
    Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B
    Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
    Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
    Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin analogues as SARS-CoV-2 main protease inhibitors:
    Farhat A; Ben Hlima H; Khemakhem B; Ben Halima Y; Michaud P; Abdelkafi S; Fendri I
    Bioengineered; 2022 Feb; 13(2):3350-3361. PubMed ID: 35048792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2.
    Stefaniu A; Pirvu L; Albu B; Pintilie L
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33321862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
    Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M
    Bharadwaj KK; Sarkar T; Ghosh A; Baishya D; Rabha B; Panda MK; Nelson BR; John AB; Sheikh HI; Dash BP; Edinur HA; Pati S
    Appl Biochem Biotechnol; 2021 Oct; 193(10):3371-3394. PubMed ID: 34212286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL
    Jukič M; Janežič D; Bren U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33316996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
    Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease.
    Sur VP; Sen MK; Komrskova K
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
    Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
    J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants as Potential SARS-CoV-2 M
    Abo Elmaaty A; Eldehna WM; Khattab M; Kutkat O; Alnajjar R; El-Taweel AN; Al-Rashood ST; Abourehab MAS; Binjubair FA; Saleh MA; Belal A; Al-Karmalawy AA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue Biotechnology: Computational Screening of
    Ibrahim MAA; Abdelrahman AHM; Atia MAM; Mohamed TA; Moustafa MF; Hakami AR; Khalifa SAM; Alhumaydhi FA; Alrumaihi F; Abidi SH; Allemailem KS; Efferth T; Soliman ME; Paré PW; El-Seedi HR; Hegazy MF
    Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.